Drugs / VECAM
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01059383 | Dec 2009 → Jun 2011 | gastroesophageal reflux disease | Vecta Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VECAM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01059383 ↗ |
| Route | Oral | “oral administration of VECAM 40/300 administered at bedtime” NCT01059383 ↗ |